We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $15.6B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$1.42B
Cap. Flow
+$81.1M
Cap. Flow %
0.52%
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407

Sector Composition

Rank Sector Weight
1 Industrials 19.5%
2 Financials 16.81%
3 Miscellaneous 15.64%
4 Technology 13.57%
5 Healthcare 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRUS icon
851
Kura Sushi USA
KRUS
$537M
$86.1K ﹤0.01%
1,496
+314
+27% +$17.2K
TDAY
852
USA Today Co
TDAY
$929M
$81.3K ﹤0.01%
9,511
-13,385
-58% -$101K
AMR icon
853
Alpha Metallurgical Resources
AMR
$2.86B
$75.7K ﹤0.01%
+459
New +$87.5K
HMN icon
854
Horace Mann Educators
HMN
$2.06B
$74K ﹤0.01%
+1,432
New +$66.5K
MELI icon
855
Mercado Libre
MELI
$100B
$73K ﹤0.01%
+43
New +$73.4K
AVAH icon
856
Aveanna Healthcare
AVAH
$2.96B
$72.7K ﹤0.01%
8,484
+8,483
+848,300% +$59.8K
NBIS
857
Nebius Group N.V.
NBIS
$61.5B
$71.3K ﹤0.01%
+258
New +$51.1K
CTMX icon
858
CytomX Therapeutics
CTMX
$808M
$71.1K ﹤0.01%
+18,972
New +$72.4K
OSIS icon
859
OSI Systems
OSIS
$3.25B
$65.8K ﹤0.01%
+301
New +$73.7K
CAI
860
Caris Life Sciences
CAI
$7.08B
$65.1K ﹤0.01%
3,655
+3,649
+60,817% +$65.3K
VG
861
Venture Global Inc
VG
$36.1B
$63.7K ﹤0.01%
5,722
-877,825
-99% -$11.1M
RARE icon
862
Ultragenyx Pharmaceutical
RARE
$1.51B
$62.1K ﹤0.01%
+1,861
New +$46.2K
MGM icon
863
MGM Resorts International
MGM
$10.4B
$61.9K ﹤0.01%
+1,295
New +$53.8K
BANR icon
864
Banner Corp
BANR
$2.61B
$61.8K ﹤0.01%
930
-19,690
-95% -$1.28M
PL icon
865
Planet Labs
PL
$6.59B
$61.7K ﹤0.01%
+1,862
New +$68.8K
OMF icon
866
OneMain Financial
OMF
$7.44B
$61K ﹤0.01%
+1,000
New +$56.3K
LYTS icon
867
LSI Industries
LYTS
$754M
$59.1K ﹤0.01%
+2,222
New +$51.4K
AVAV icon
868
AeroVironment
AVAV
$7.35B
$57.9K ﹤0.01%
+351
New +$62.8K
NAVN
869
Navan Inc
NAVN
$7.07B
$53.4K ﹤0.01%
+2,336
New +$42.8K
TMC icon
870
TMC The Metals Company
TMC
$1.96B
$49K ﹤0.01%
+11,058
New +$57.6K
STUB
871
StubHub Holdings
STUB
$2.52B
$46.8K ﹤0.01%
+3,633
New +$32.1K
MRNA icon
872
Moderna
MRNA
$58.1B
$46.1K ﹤0.01%
+659
New +$34.1K
CRSP icon
873
CRISPR Therapeutics
CRSP
$5.39B
$45.1K ﹤0.01%
+827
New +$43.6K
INVX
874
Innovex International
INVX
$2.1B
$42.7K ﹤0.01%
1,721
+574
+50% +$15.6K
PFSI icon
875
PennyMac Financial
PFSI
$3.81B
$41.2K ﹤0.01%
473
-11,913
-96% -$1.04M

Similar funds

Freestone Grove Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.

  • Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
  • Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
  • Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
  • Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
  • Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
  • Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
  • Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.